Based on 1 Wall Street analysts offering 12 month price targets for Atea Pharmaceuticals in the last 3 months. The average price target is $6.20 with a high forecast of $6.20 and a low forecast of $6.20. The average price target represents a 83.98% change from the last price of $3.37.

eyJuYXZpZ2F0b3IiOnsiZGlzYWJsZWQiOnRydWV9LCJleHBvcnRpbmciOnsiZW5hYmxlZCI6ZmFsc2V9LCJ0aXRsZSI6eyJ0ZXh0IjpudWxsfSwiY2hhcnQiOnsiaGVpZ2h0IjoyMDAsInN0eWxlIjp7ImZvbnRGYW1pbHkiOiJSb2JvdG8gRmxleCIsImZvbnRXZWlnaHQiOiI0MDAiLCJjb2xvciI6IiM1ZDVkNWUifX0sInlBeGlzIjp7ImxhYmVscyI6eyJzdHlsZSI6eyJjb2xvciI6ImluaGVyaXQifX0sInZpc2libGUiOmZhbHNlfSwicGxvdE9wdGlvbnMiOnsic2VyaWVzIjp7InN0YXRlcyI6eyJpbmFjdGl2ZSI6eyJvcGFjaXR5IjoxfX19fSwieEF4aXMiOnsibGFiZWxzIjp7InN0eWxlIjp7ImNvbG9yIjoiaW5oZXJpdCJ9fSwidmlzaWJsZSI6ZmFsc2V9LCJsZWdlbmQiOnsic3ltYm9sUmFkaXVzIjowLCJzeW1ib2xQYWRkaW5nIjo0LCJzeW1ib2xIZWlnaHQiOjE0LCJib3JkZXJXaWR0aCI6MCwic3ltYm9sV2lkdGgiOjE0LCJhbGlnbiI6ImxlZnQiLCJ2ZXJ0aWNhbEFsaWduIjoiYm90dG9tIiwiZW5hYmxlZCI6ZmFsc2V9LCJ0b29sdGlwIjp7ImJhY2tncm91bmRDb2xvciI6IndoaXRlIn0sImNyZWRpdHMiOnsiZW5hYmxlZCI6ZmFsc2V9LCJhY2Nlc3NpYmlsaXR5Ijp7ImRlc2NyaXB0aW9uIjoiIn0sInNlcmllcyI6W3sidHlwZSI6ImFyZWEiLCJkYXRhIjpbXX1dfQ==

Highest Price Target$6.20

Average Price Target$6.20

Lowest Price Target$6.20

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

AVIR Analyst Recommendation Trends

Currently, no data available

Please return soon. This page is being updated.

Each month's total comprises the sum of three months' worth of ratings.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

AVIR Financial Forecast

AVIR Earnings Forecast

Next quarter’s earnings estimate for AVIR is -$0.29 with a range of -$0.38 to -$0.13. The previous quarter’s EPS was -$0.37. AVIR beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 40.82% of the time in the same period. In the last calendar year AVIR has Outperformed its overall industry.

AVIR Sales Forecast

Next quarter’s sales forecast for AVIR is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. AVIR beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 36.99% of the time in the same period. In the last calendar year AVIR has Preformed in-line its overall industry.

AVIR Stock Forecast FAQ

What is AVIR’s average 12-month price target, according to analysts?

Based on analyst ratings, Atea Pharmaceuticals’s 12-month average price target is $6.20.

What is AVIR’s upside potential, based on the analysts’ average price target?

Atea Pharmaceuticals has 83.98% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is AVIR a Buy, Sell or Hold?

Atea Pharmaceuticals has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.

What is Atea Pharmaceuticals’s price target?

The average price target for Atea Pharmaceuticals is $6.20. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $6.20 ,the lowest forecast is $6.20. The average price target represents 83.98% Increase from the current price of $3.37.

What do analysts say about Atea Pharmaceuticals?

Atea Pharmaceuticals’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of AVIR?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing